Nabla

Nabla

AI-powered clinical documentation assistant

Overview

Nabla builds ambient AI for healthcare to streamline clinical documentation and workflows. Its flagship Nabla Copilot listens to doctor–patient conversations in real time and automatically creates structured notes that can be entered into Epic, Cerner, or athenahealth, across 55 specialties and 35 languages with customizable settings. It differentiates itself with deep EHR integration, real-time transcription and note generation, broad specialty/language coverage, and growing enterprise adoption as it expands into broader AI-assisted clinical tasks. The goal is to cut administrative time and clinician burnout by handling documentation and expanding AI-powered clinical support.

About Nabla

Simplify's Rating
Why Nabla is rated
B-
Rated B on Competitive Edge
Rated B on Growth Potential
Rated C on Differentiation

Industries

Data & Analytics

Enterprise Software

AI & Machine Learning

Healthcare

Company Size

51-200

Company Stage

Series C

Total Funding

$112.7M

Headquarters

Paris, France

Founded

2018

Get referred to Nabla

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • July 28, 2026: on-device Mac dictation cuts cloud costs and privacy objections.
  • University of Toledo Health reduced chart-closure time 29% during an eight-week Nabla pilot.
  • M Health Fairview and CVS Health deployments validate enterprise expansion beyond self-serve clinicians.

What critics are saying

  • Microsoft Dragon Copilot and Abridge squeeze Nabla’s enterprise deals by 2027.
  • Brian Manning’s July 21, 2026 CEO transition risks distracting sales execution.
  • Epic dependency and Apple-specific dictation limit Nabla outside those ecosystems.

What makes Nabla unique

  • July 28, 2026: Nabla Dictation for Mac runs fully on-device with Epic integration.
  • Nabla supports 35+ languages and 190 health systems across 100,000+ clinicians.
  • Alexandre LeBrun’s AMI Labs partnership gives Nabla early access to frontier AI research.

Help us improve and share your feedback! Did you find this helpful?

Funding

Total Funding

$112.7M

Above

Industry Average

Funded Over

3 Rounds

Series C funding is usually for startups that are doing well and are looking for more money to fuel major growth, such as acquiring other companies, expanding into global markets, or launching new product lines. Investors typically include larger venture capital firms and private equity.
Series C Funding Comparison
Above Average

Industry standards

$50M
$50M
Medium
$62M
SeatGeek
$70M
Nabla
$100M
Oura

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Unlimited Paid Time Off

Paid Sick Leave

Parental Leave

Stock Options

Home Office Stipend

Flexible Work Hours

Growth & Insights and Company News

Headcount

6 month growth

1%

1 year growth

2%

2 year growth

5%
Healthcare Dive
Aug 26th, 2026
Suki launches AI dictation tool with EHR integration capabilities.

Suki launches AI dictation tool with EHR integration capabilities. Providers might choose the tool when documenting complex surgical procedures or medical codes to ensure the highest level of precision, Suki says. Published Aug. 26, 2026 Dive brief: * Artificial intelligence documentation startup Suki has launched a dictation tool that transcribes speech into text word-for-word, the company announced Tuesday. * The company's flagship product is a scribe that listens passively in doctors' offices and turns patient-provider conversations into summarized clinical notes, rather than a transcript. But the new tool captures spoken word verbatim, which can be useful for providers working with complicated medical jargon, Suki said in a press release. * The tool can be integrated into Epic and Meditech's electronic health records systems. Health tech companies can also embed it directly into their own products, eliminating the need to build tools from scratch, according to Suki. Dive insight: Suki says its new AI-powered dictation tool, which providers can deploy on its own or alongside Suki's ambient clinical documentation tool, allows clinicians to choose the most appropriate documentation method for each patient visit. The tool uses automatic speech recognition, a branch of AI that actively learns a user's vocabulary over time and removes filler words to make the notes more concise. Providers might choose the verbatim tool, Suki Dictation, when documenting complex surgical procedures or medical codes to ensure the highest level of precision, which is critical for accurate reimbursements, the company said. Meanwhile, a doctor having a more routine conversation with a patient might prefer an ambient listening tool that generates notes during the appointment and summarizes key talking points. Clinical dictation has progressed from in-person stenographers to today's AI-assisted tools embedded into EHR systems. Transcribing speech to text is not new technology, but Suki says leveraging AI to do it provides more value for clinicians. According to Abhi Pathak, Suki's chief product officer, the company's dictation tool shares a base infrastructure with its ambient documentation product, laying the groundwork for future products such as AI-backed procedure note generation, conversational voice editing and intelligent voice commands. Clinical documentation is one of the most popular use cases for AI in healthcare. Research shows that among hospitals using Epic's EHR, 63% use AI for documentation. AI scribes have been tied to time savings and an uptick in clinician job satisfaction. Suki is competing in a fierce market dominated by well-funded startups and EHR companies offering their own native AI scribes. Suki's dictation tool comes more than a year after one of its competitors, health tech startup Nabla, launched a dictation tool. Microsoft Dragon Copilot also offers dictation alongside ambient documentation.

PR Newswire
Jul 28th, 2026
Nabla launches on-device clinical dictation for Mac with Epic integration

Nabla has launched Nabla Dictation for Mac, the first fully on-device clinical dictation app designed natively for macOS. The product combines on-device speech recognition with Epic integration, extending AI capabilities beyond patient encounters to support tasks like managing inbox messages and drafting referrals. The application processes all speech on-device using Apple's Core ML and Neural Engine, eliminating cloud dependency whilst maintaining compatibility with existing dictation hardware including PowerMic and SpeechMike microphones. The company rebuilt its entire speech stack using Apple native technologies like Swift and Core ML. Forty-four per cent of Nabla's active clinicians work on Apple devices. The platform is trusted by over 100,000 clinicians across 190 health systems, including M Health Fairview, and supports more than 35 languages whilst integrating with all major electronic health records systems.

SpeechTech Magazine
Jul 28th, 2026
Nabla launches Dictation for Mac.

Nabla launches Dictation for Mac. Nabla, providers of artificial intelligence assistants in clinical care, has introduced a fully on-device clinical dictation app, Nabla Dictation for Mac, combining on-device speech recognition with deep Epic electronic health record integration. For health systems operating on Apple devices, Nabla is combining ambient documentation with medical-grade dictation on Mac in a single AI-native experience. The offering supports documentation, communication, and care coordination tasks through one unified voice layer while maintaining compatibility with existing dictation hardware, including PowerMic and SpeechMike microphones. "For decades, clinicians have been forced to adapt their workflows to software," said Laurent Landowski, chief product officer of Nabla, in a statement. "We believe it's time for software to adapt to clinicians. Voice is becoming the most natural interface for clinical work, but healthcare has been held back by fragmented tools and workflows that weren't designed for the AI era. Our vision is a future where clinicians can move through their entire day using a single, intelligent voice layer built around how care is actually delivered." To deliver the Mac app, Nabla rebuilt its full speech stack, including voice activation, speech-to-text, and medical post-processing using Apple native technologies like Swift and Core ML, and taking advantage of the power of Apple silicon. Using Apple's Core ML Tools, the team migrated years of PyTorch-based speech models onto Apple Silicon. On-device, the models are optimized for the Apple Neural Engine. This enables the low latency and efficiency required for medical-grade dictation, with no audio sent to servers and no cloud dependency. "Core ML and the Apple Neural Engine made it possible for us to bring our entire speech pipeline on-device for Mac without compromising the performance clinicians expect from medical-grade dictation," Landowski said. "That means clinicians get the speed and responsiveness they need, while keeping speech processing entirely on their device."

Nabla
Jul 28th, 2026
Nabla launches Medical-Grade Dictation Product built for Apple devices.

Nabla launches Medical-Grade Dictation Product built for Apple devices. July 28, 2026 NEW YORK, July 28, 2026 /PRNewswire/ - Nabla, one of the most widely adopted AI assistants in clinical care, today announced the first fully on-device clinical dictation app, Nabla Dictation for Mac, designed natively for macOS. By combining on-device speech recognition with deep Epic integration, the solution represents the next step in Nabla's vision for a more seamless, voice-driven future that extends AI beyond the patient encounter and enables clinicians to spend more time focused on their patients. Bringing Ambient Documentation Together with Medical-Grade Dictation for Mac Much of a clinician's day is still spent on administrative work that happens outside the visit itself. While ambient AI has helped streamline documentation during the patient conversation, providers still spend significant time managing inbox messages, drafting referrals, coordinating follow-up care, and completing other tasks throughout the day. Many of these activities still rely on traditional dictation tools and fragmented workflows, creating additional complexity across the broader care experience. For health systems operating on Apple devices, Nabla is combining ambient documentation with medical-grade dictation on Mac in a single AI-native experience. The offering is designed to support documentation, communication, and care coordination tasks through one unified voice layer while maintaining compatibility with existing dictation hardware, including PowerMic and SpeechMike microphones - allowing health systems to modernize without replacing established infrastructure or disrupting the workflows clinicians already rely on. "For decades, clinicians have been forced to adapt their workflows to software," said Laurent Landowski, Chief Product Officer at Nabla. "We believe it's time for software to adapt to clinicians. Voice is becoming the most natural interface for clinical work, but healthcare has been held back by fragmented tools and workflows that weren't designed for the AI era. Our vision is a future where clinicians can move through their entire day using a single, intelligent voice layer built around how care is actually delivered." Delivering On-Device Clinical Dictation Nabla's dictation capabilities are the result of more than two years of investment in speech recognition technology, shaped by feedback from thousands of practicing clinicians and purpose-built for the complexity of medical language and documentation. To deliver the best experience and performance on the Mac, Nabla rebuilt its full speech stack - voice activation, speech-to-text, and medical post-processing - using Apple native technologies like Swift and Core ML, and taking advantage of the power of Apple silicon.[1] Using Apple's Core ML Tools, the team migrated years of PyTorch-based speech models onto Apple Silicon. On-device, the models are optimized for the Apple Neural Engine. This enables the low latency and efficiency required for a medical-grade dictation experience, with no audio sent to a server and no cloud dependency. "Core ML and the Apple Neural Engine made it possible for us to bring our entire speech pipeline on-device for Mac without compromising the performance clinicians expect from medical-grade dictation," said Landowski. "That means clinicians get the speed and responsiveness they need, while keeping speech processing entirely on their device." Designed to run entirely on-device, the new dictation experience is built to deliver the speed, privacy, and responsiveness clinicians expect while keeping clinical conversations under the clinician's control. By bringing enterprise-grade clinical dictation directly on Mac and processing all speech on-device, Nabla enhances privacy, gives clinicians greater control over their data, and eliminates the need to send audio to the cloud. Leveraging Core ML and the Apple Neural Engine, Nabla also reduces the cloud infrastructure and token costs associated with server-based speech processing while delivering a fast, responsive experience. As one of the few healthcare AI companies developing fully on-device clinical dictation integrated with Epic, Nabla aims to bring together native Apple performance and the EHR workflows clinicians already rely on every day. For health systems that have historically lacked enterprise-grade dictation options, the collaboration also provides a modern, AI-native alternative without requiring clinicians to change how they work on a Mac. Forty-four percent of active clinicians using Nabla today work on Apple devices, including significant adoption among Epic organizations and virtual-first care providers. Trusted by clinicians and healthcare organizations nationwide, this announcement builds on Nabla's growing adoption as a trusted enterprise partner for health systems modernizing care delivery workflows. Organizations such as M Health Fairview have already deployed Nabla at scale, demonstrating demand for an AI-native, unified voice experience that reduces administrative burden and supports clinicians and care teams across the patient journey.

PR Newswire
Jul 21st, 2026
Nabla appoints Brian Manning as CEO to scale clinical AI across 190 healthcare organisations

Nabla, a clinical AI company, has appointed Brian Manning as chief executive officer. Manning brings over 20 years of experience scaling technology businesses and building commercial teams. Most recently, Manning served as president and chief revenue officer of Bamboo Health, where he helped scale the company to more than $140 million in annual recurring revenue. He previously worked at PatientPing and Zocdoc. Manning joins as Nabla supports more than 190 healthcare organisations, 100,000 clinicians, and 40 million patient encounters annually. The platform is deployed across health systems including CVS Health, UCLA Health, and University of Iowa Health Care. Alex LeBrun, Nabla's co-founder and former chief executive, will continue as executive chairman and chief AI officer, leading the company's AI strategy and product vision.

Recently Posted Jobs

Sign up to get curated job recommendations

Nabla is Hiring for 14 Jobs on Simplify!

Find jobs on Simplify and start your career today

Don't see your dream role? Check out thousands of other roles on Simplify. Browse all jobs →